🔗 Share this article

An underground economy for unlicensed weight-loss medications is propelled by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Experimental Drug Gaining Popularity Online

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Viewers are urged to contact these profiles directly for supplier links, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a robust trade exists on Telegram, where communities with thousands of members share “before and after” photos, administration instructions and assertions of rapid British shipping. Sellers promote the substance there before redirecting buyers to WhatsApp for transactions.

Learning About Retatrutide

This medication is an investigational injection created by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.

Medical Professionals Voice Worries

Nevertheless, physicians and chemists have warned that the sale of what is still an unlicensed drug in the UK is a cause for concern and could lead to individuals administering substances of uncertain source.

Some professionals said the demand for retatrutide could be linked to the rising price of licensed slimming products such as Mounjaro.

Legal Position and Implementation

Marketing retatrutide on social media or messaging apps is prohibited in the UK, as it is an unapproved drug that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.

Some content creators try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still breach pharmaceutical, advertising, and consumer regulations, risking penalties, prosecution or prison.

Platform Reaction and Content Elimination

According to TikTok, the platform has taken down violative material and banned associated hashtags and query recommendations. The organization stated it was dedicated to keeping the service safe and allocating resources in strengthening compliance measures.

Online Trading Operations

Research also found communities with up to 9,000 members marketing retatrutide using Telegram's integrated discovery tool, which functions like a public directory. Entering “retatrutide” instantly brings up groups with thousands of users, populated with photos of weight loss, glowing reviews and detailed instructions for preparing or injecting at home.

Within moments of entering one community, a vendor shared WhatsApp details, where most transactions occur. The vendor sent an instruction manual and guaranteed shipping within 48 hours. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about body mass, health issues or previous experience.

Product Details and Costs

Inside these communities, messages display black plastic packages with Royal Mail labels, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at residence with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20mg. When questioned how much time a injector should be used, vendors give contradictory responses varying between a several days to “depends on your body”.

Platform Oversight and Safety Actions

A spokesperson for the messaging service stated it actively monitored dangerous material on its service including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are injecting substances they can’t verify. Even if the research behind this drug is sound, these digital products may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to current price rises for approved slimming drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit treatments are extremely risky. You cannot know what’s inside or whether the conditions they were made in was clean,” she said.

Her team has previously encountered individuals harmed by self-injection from unconfirmed sources. “We recognize the disappointment, but buying from Telegram or communication platforms is taking chances with your well-being,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A spokesperson from Eli Lilly said retatrutide was in third stage clinical trials and had not been evaluated or authorized by any government authority globally. “Consequently at this point no one can market [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a company experimental substance not yet authorized … may expose patients to potentially serious health risks”.